Renaissance Technologies LLC lifted its holdings in shares of HCP, Inc. (NYSE:HCP) by 1.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 137,300 shares of the real estate investment trust’s stock after acquiring an additional 2,500 shares during the quarter. Renaissance Technologies LLC’s holdings in HCP were worth $3,545,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Piedmont Investment Advisors LLC purchased a new stake in shares of HCP during the second quarter valued at approximately $142,000. Reliance Trust Co. of Delaware purchased a new stake in shares of HCP during the second quarter valued at approximately $211,000. Atlas Brown Inc. purchased a new stake in shares of HCP during the second quarter valued at approximately $226,000. Private Vista LLC purchased a new stake in shares of HCP during the first quarter valued at approximately $234,000. Finally, Pennsylvania Trust Co purchased a new stake in shares of HCP during the second quarter valued at approximately $247,000. 88.30% of the stock is owned by institutional investors.
NYSE:HCP opened at $26.40 on Friday. The company has a debt-to-equity ratio of 1.37, a current ratio of 0.51 and a quick ratio of 0.51. HCP, Inc. has a 1 year low of $21.48 and a 1 year high of $27.62. The firm has a market capitalization of $12.11 billion, a price-to-earnings ratio of 13.43, a PEG ratio of 6.47 and a beta of 0.28.
A number of analysts recently commented on the company. ValuEngine raised HCP from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 26th. Morgan Stanley raised their target price on HCP from $23.50 to $25.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 16th. Robert W. Baird raised their target price on HCP from $24.00 to $26.00 and gave the stock a “neutral” rating in a research report on Thursday, August 9th. Cantor Fitzgerald began coverage on HCP in a research report on Tuesday, August 7th. They issued a “neutral” rating and a $28.00 target price for the company. Finally, Zacks Investment Research raised HCP from a “sell” rating to a “hold” rating in a research report on Tuesday, August 7th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $26.54.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Article: Marijuana Stocks
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.